Population pharmacokinetics meets microdialysis: Benefits, pitfalls and necessities of new analysis approaches for human microdialysis data

European Journal of Pharmaceutical Sciences

Volumn 57, Issue 1, 2014, Pages 68-73

  Schaeftlein, André ^a,b   Minichmayr, Iris K ^a,b   Kloft, Charlotte ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Graduate Research Training program PharMetrX   (Germany)

Author keywords

Data analysis; Humans; Microdialysis; NLME; PBPK; Population PBPK

Indexed keywords

DRUG; LEVOFLOXACIN;

ARTICLE; DATA ANALYSIS; DRUG DISPOSITION; DRUG MONITORING; MICRODIALYSIS; PHARMACOKINETICS; PHYSICAL CHEMISTRY; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; HUMAN; METABOLISM; REPRODUCIBILITY;

COMPUTER SIMULATION; HUMANS; MICRODIALYSIS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; REPRODUCIBILITY OF RESULTS;

EID: 84899948941     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2013.11.004     Document Type: Article

References (14)

1. S.L. Beal Population pharmacokinetic data and parameter estimation based on their first two statistical moments Drug Metab. Rev. 15 1984 173 193 (Pubitemid 14123937)
2. S. Björkman Reduction and lumping of physiologically based pharmacokinetic models: prediction of the disposition of fentanyl and pethidine in humans by successively simplified models J. Pharmacokinet Pharmacodyn. 30 2003 285 307 (Pubitemid 37352524)
3. C. Brochot, J. Tóth, and F.Y. Bois Lumping in pharmacokinetics J. Pharmacokinet Pharmacodyn. 32 2005 719 736 (Pubitemid 41772354)
4. T. Eissing et al. A computational systems biology software platform for multiscale modelling and simulation: integrating whole-body physiology, disease biology, and molecular reaction networks Front Physiol. 2 2011 4 14
5. J.V. Gobburu, and P.J. Marroum Utilisation of pharmacokinetic- pharmacodynamic modelling and simulation in regulatory decision-making Clin. Pharmacokinet. 40 2001 883 892 (Pubitemid 34066686)
6. I. Gueorguieva, I.A. Nestorov, and M. Rowland Reducing whole body physiologically based pharmacokinetic models using global sensitivity analysis: diazepam case study J. Pharmacokinet Pharmacodyn. 33 2006 1 27
7. M. Krauss et al. Using Bayesian-PBPK modelling for assessment of inter-individual variability and subgroup stratification Silico Pharmacol. 1 2013 6 17
8. I.A. Nestorov et al. Lumping of whole-body physiologically based pharmacokinetic models J. Pharmacokinet. Biopharm. 26 1998 21 46 (Pubitemid 28429460)
9. G.C. Pillai, F. Mentré, and J.-L. Steimer Non-linear mixed effects modelling - from methodology and software development to driving implementation in drug development science J. Pharmacokinet Pharmacodyn. 32 2005 161 183 (Pubitemid 41712738)
10. N. Plock, and C. Kloft Microdialysis-theoretical background and recent implementation in applied life-sciences Eur. J. Pharm. Sci. 25 2005 1 24 (Pubitemid 40602191)
11. M. Rowland, C. Peck, and G. Tucker Physiologically-based pharmacokinetics in drug development and regulatory science Annu. Rev. Pharmacol. Toxicol. 51 2011 45 73
12. Schaeftlein, A. et al., Unpublished results. New modelling approaches for microdialysis data in humans.
13. C.W. Tornøe et al. Non-linear mixed-effects pharmacokinetic/ pharmacodynamic modelling in NLME using differential equations Comput. Methods Programs Biomed. 76 2004 31 40 (Pubitemid 39094638)
14. J. Valentin et al. Basic Anatomical and Physiological Data for Use in Radiological Protection: Reference Values 2001 Springer 7-265